The Sustainable Financing team provides tools, strategic analysis and evidence to support advocacy for the adequate funding of harm reduction.
We are the only non-governmental organisation tracking harm reduction funding trends globally - including support provided by international donors and domestic governments - and the impact these have on the global HIV and other health responses.
We support advocacy for increased investment in harm reduction, including campaigning for the redirection of funding from ineffective drug law enforcement to harm reduction and work with national partners to gather evidence to inform budget advocacy.
See below for examples of our work:
.......................................................................................................................................
Harm Reduction International (HRI) inputs on PEPFAR Strategy Draft Overview Version 2.0
Harm Reduction International (HRI) welcomes the PEPFAR Strategy Draft Overview Version 2.0 and the opportunity to input.
.......................................................................................................................................
Each year more than USD 100 billion is estimated to be spent on global drug law enforcement. This is over 750 times the amount allocated to harm reduction services for people who use drugs.
.......................................................................................................................................
Failure To Fund: The continued crisis for harm reduction funding in low- and middle-income countries
This report explores the state of harm reduction funding in low- and middle-income countries, drawing upon existing public data on domestic funding and information collected from international harm reduction donors. The data shows that we are further away from meeting the needs of people who use drugs than ever before.
.......................................................................................................................................
This briefing compiles evidence of the impact of the multi-country grant Harm Reduction Advocacy in Asia (HRAsia), funded by the Global Fund’s Catalytic Investments between 2017- 2020. It also highlights a number of ways in which multi-country grants for harm reduction play a crucial role in augmenting the potential of country-led programming within Global Fund country grants.
.......................................................................................................................................
Budget Advocacy GuideHow money is collected and distributed through public budgets influences the lives of millions of people in every country in the world. Those decisions might ensure food and shelter for many, or deprive others from essential healthcare services. Budget advocacy, which is a tool to influence those decisions, can make an impact on millions of lives.
.......................................................................................................................................
The impact of COVID-19 on harm reduction in seven Asian countries
This briefing summarises evidence from civil society in seven Asian countries (Cambodia, India, Indonesia, Nepal, Thailand, the Philippines and Vietnam) and provides recommendations to donors and governments on protecting harm reduction in the COVID-19 era.
.......................................................................................................................................
$100 billion is spent on global drug law enforcement every year, but just $188 million is spent on harm reduction. This means that we spend more than 500 times the amount on punitive responses than we do on life-saving services for people who use drugs. We must redirect this funding towards life-saving, cost-effective, and rights-based harm reduction interventions.
.......................................................................................................................................
The Impact of a Multi-Country Advocacy Grant on Progress towards 90-90-90 for people who use drugs
This briefing compiles evidence of the impact of the multi-country grant Harm Reduction Advocacy in Asia (HRAsia), funded by the Global Fund’s Catalytic Investments between 2017- 2020. It also highlights a number of ways in which multi-country grants for harm reduction play a crucial role in augmenting the potential of country-led programming… Read more
.......................................................................................................................................
Costing Tools for Harm Reduction Advocates
Harm Reduction International worked with researchers, civil society and community experts to design costing tools to help advocates assess national harm reduction funding and to capture information on the cost of drug control and law enforcement in a country.
.......................................................................................................................................
HRI Working Papers - Supporting Global Fund Country Proposals
.......................................................................................................................................
Summing it up: Building evidence to inform advocacy for harm reduction funding in Asia
Harm Reduction International developed tools for assessing national harm reduction investment and spending on drug law enforcement. This report presents the research findings generated by these tools in seven Asian countries.
.......................................................................................................................................
Making the
investment case: Cost-effectiveness evidence for harm reduction
This briefing compiles geographically diverse evidence to enable advocates to make the case for the cost-effectiveness of harm reduction.
.......................................................................................................................................
........................................................................................................................................
History was made last week in Lyon, when governments, philanthropic donors and the private sector pledged US$14 billion for the Sixth Global Fund Replenishment, more than any other global health institution has ever raised.
........................................................................................................................................
People
before politics: HR19 call to action on harm reduction funding and Global Fund replenishment
View and add your organisation to this Harm Reduction International Conference 2019 (HR19) call to action around harm reduction funding and the Global Fund's replenishment in 2019.
........................................................................................................................................
Joint Briefing with
Frontline AIDS on Global Fund Catalytic Investments for Harm Reduction
This briefing, developed in collaboration with Frontline AIDS, compiles evidence on the crucial nature of the Global Fund's catalytic investment funds for harm reduction.
........................................................................................................................................
The lost decade: Neglect for
harm reduction funding and the health crisis among people who use drugs
Our 2018 publication tracked harm reduction funding in low- and middle-income countries (LMICs), showing a falls in international donor funding over a decade.
........................................................................................................................................
Harm reduction is an evidence-based and cost-effective approach. It aims to keep people who use drugs, their families and communities safe and healthy. Our 10 by 20 campaign provides tools to advocates to push for the redirection of funding from drug law enforcement to harm reduction.
........................................................................................................................................
Global Fund Harm Reduction Advocacy in Asia
Harm Reduction International’s (HRI) preliminary research into the harm reduction funding landscape in Asia finds that there is a paucity of funding for HIV prevention, treatment, and care programmes for people who use drugs.
........................................................................................................................................
The Case for a Harm Reduction
Decade: Progress, potential and paradigm shifts
HIV-related deaths and new HIV infections among people who inject drugs could be almost entirely eliminated by 2030 with just a tiny shift in global drug control spending. Find out more in our 2016 study.
........................................................................................................................................
Harm Reduction Investment in the
European Union: Current funding, challenges and successes
Europe is the birthplace of harm reduction, and the region where the successes of this approach in averting epidemics can be most plainly seen. However, austerity, international donor retreat and poor political support are severely limiting harm reduction responses in several countries in the EU.
........................................................................................................................................
The funding crisis for harm
reduction
Our 2014 research with the International Drug Policy Consortium (IDPC) and International HIV/AIDS Alliance showed that without significant changes in government and donor priorities, the global HIV epidemic will not be halted.
........................................................................................................................................
Three cents a day is not enough:
Resourcing HIV-related harm reduction on a global basis
Our 2010 report found that only $160 million was being invested annually in harm reduction, with only a fraction going to direct services for people who use drugs.
........................................................................................................................................
